| 8962654 |
3,4-dihydroisoquinolin-2(1H)-yl compounds |
Christopher David Beadle, David Coates, Junliang HAO, Joseph H. Krushinski, Jr., Matthew Robert Reinhard +1 more |
2015-02-24 |
$85,041,000 |
| 8420654 |
1,5-Diphenyl-pyrrolidin-2-one compounds as CB-1 ligands |
— |
2013-04-16 |
$124,968,000 |
| 8299061 |
Inhibitors of diacylglycerol acyltransferase |
Macklin Brian Arnold, Thomas Beauchamp, Emily J. Canada, Erik James Hembre, Jianliang Lu +2 more |
2012-10-30 |
|
| 8202873 |
2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor antagonists |
Valentina Badescu, Anne Marie Camp, Barry Peter Clark, Michael Philip Cohen, Sandra Ann Filla +6 more |
2012-06-19 |
$208,205,000 |
| 8168659 |
1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators |
David Scott Coffey, Jingdan Hu, Stacy Jo Keding, Joseph H. Krushinski, Jr., David E. Tupper |
2012-05-01 |
$207,727,000 |
| 8044090 |
N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
Zhaogen Chen, Michael Philip Cohen, Matthew Joseph Fisher, Bruno Giethlen, James Gillig +2 more |
2011-10-25 |
$74,886,000 |
| 7998985 |
1,5-diphenyl-3-pyridinylamino-1,5-dihydropyrrolidin-2-one as CB1 receptor modulator |
— |
2011-08-16 |
$54,669,000 |
| 7384934 |
Piperazine substituted aryl benzodiazepines |
Thomas D. Aicher, Zhaogen Chen, Yvan LeHuerou, Fionna Mitchell Martin, Marta Pineiro-Nunez +4 more |
2008-06-10 |
$65,113,000 |
| 7314937 |
Non-imidazole aryl alkylamines compounds as histamine H3 receptor antagonists, preparation and therapeutic uses |
Lisa Selsam Beavers, Robert Alan Gadski, Philip Arthur Hipskind, Craig W. Lindsley, Karen L. Lobb +4 more |
2008-01-01 |
|
| 7230011 |
Benzenesulfonic acid indol-5-yl esters as antagonists of the 5ht6 receptor |
Sandra Ann Filla, Michael E. Flaugh, James Gillig, Lawrence Joseph Heinz, Joseph H. Krushinski, Jr. +3 more |
2007-06-12 |
$57,356,000 |
| 7214673 |
Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders |
Thomas D. Aicher, Zhaogen Chen, Joseph H. Krushinski, Jr., Yvan Le Huerou, Marta Pineiro-Nunez +6 more |
2007-05-08 |
$92,297,000 |
| 7157488 |
N-(2-Arylethyl) benzylamines as antagonists of the 5-HT6 receptor |
Zhaogen Chen, Michael Philip Cohen, Matthew Joseph Fisher, Bruno Giethlen, James Gillig +2 more |
2007-01-02 |
|
| 6864262 |
1-(2-m-methanesulfonamidophenylethyl)-4-(m-trifluoromethylphenyl) piperazine and pharmaceutically acceptable salts and solvents thereof |
Dennis C. Thompson, Karl Thor |
2005-03-08 |
$284,106,000 |
| 6777428 |
5-HT1f agonist |
Joseph H. Krushinski, Jr., Vincent Mancuso, Freddy Andre Napora |
2004-08-17 |
$380,662,000 |
| 6608079 |
Indole derivatives and their use as 5-HT1F agonists |
Yao-Chang Xu |
2003-08-19 |
$152,467,000 |
| 6355674 |
Aminotetralins as 5-HT1D &agr; Agonists |
Clint Duane Walker, Yao-Chang Xu |
2002-03-12 |
$106,692,000 |
| 6172073 |
Compounds having effects on serotonin-related systems |
James E. Audia, David J. Hibschman, Joseph H. Krushinski, Jr., Thomas E. Mabry, Jeffrey S. Nissen +4 more |
2001-01-09 |
$400,731,000 |
| 6133290 |
5-HT.sub.1F agonists |
Joseph H. Krushinski, Jr. |
2000-10-17 |
$162,752,000 |
| 6117882 |
5-HT.sub.4 agonists and antagonists |
Marlene L. Cohen, Dennis C. Thompson |
2000-09-12 |
$216,560,000 |
| 6069152 |
5-HT.sub.4 agonists and antagonists |
Marlene L. Cohen, Dennis C. Thompson |
2000-05-30 |
$181,428,000 |
| 5998622 |
5-HT.sub.1F agonists intermediates |
Sandra Ann Filla, Kirk Willis Johnson, Lee A. Phebus |
1999-12-07 |
$63,132,000 |
| 5962474 |
5-substituted-3-(1,2,3,6-tetrahydropyridin-4-yl)-and 3-(piperidin-4-yl)-1h-indoles: 5-HT.sub.1F agonists |
James E. Audia, Bruce A. Dressman, James J. Droste, James E. Fritz, Stephen W. Kaldor +5 more |
1999-10-05 |
$103,905,000 |
| 5919936 |
Nitropyridine compound |
Sandra Ann Filla, Kirk Willis Johnson, Lee A. Phebus |
1999-07-06 |
$61,549,000 |
| 5905084 |
5-HT.sub.IF -agonists effective in treating migraine |
Sandra Ann Filla, Brian Michael Mathes |
1999-05-18 |
$314,968,000 |
| 5874427 |
Substituted heteroaromatic 5-HT.sub.1F agonists |
Sandra Ann Filla, Joseph H. Krushinski, Jr. |
1999-02-23 |
$414,692,000 |
